Kors Van Der Ent

This study tested whether a three-drug combination (Dirocaftor/Posenacaftor/Nesolicaftor) could help adults with cystic fibrosis who have rare genetic mutations not covered by existing treatments. Researchers first used patients' own lab-grown intestinal tissue samples to predict…